Back to Directory
research logo

Alnylam Pharmaceuticals | Company Profile - Revenue, Headcount, Tech Stack, Contacts

3/11/2026

Contact Information

πŸ‘€
Alnylam Pharmaceuticals
🏒
Alnylam Pharmaceuticals
πŸ“
675 W Kendall St, Cambridge, Massachusetts 02142, US

Industry & Market

Primary Industry
research
Location
Cambridge, Massachusetts, United States
Public Trading
NASDAQ: ALNY

Company Metrics

πŸ‘₯Total Employees
1,091
βš™οΈEngineering
83
πŸ’ΌSales Team
158
πŸ“ˆMarketing
72
πŸ“…Founded
2002
πŸ’°Revenue
3.7B

Funding Information

Market Cap
$42.5B
Annual Revenue
$3,713,937,000
Publicly traded company

Headcount Distribution

Total Employees
1,091
Departments
19

By Department

Department Breakdown

Business Development
Operations
Sales
Education
Engineering
Marketing
Others

Technology Stack

Analytics & Tracking

Google AnalyticsGoogle Tag ManagerSAP Predictive AnalyticsSalesforce CRM Analytics

Social & Marketing

Facebook Custom AudiencesFacebook Login (Connect)Facebook WidgetLinkedin Marketing Solutions

Development

Bootstrap Framework

Video & Media

VimeoYouTube

Email & Communication

Outlook
Total: 76 technologies

Keywords & Focus Areas

biotechpharmaceuticalsbiopharmadrug developmentrare diseasesrnaihealthcarebiotechnology: pharmaceutical preparationshealth carebiotechnology researchgene silencinggenetic disorder therapiestargeted gene silencingrnai therapeuticsrnai gene therapyrnai delivery platformsbiotechnologyrnai clinical trialsrnai for metabolic diseasesrnai pipeline+10 more
30 total keywords

Alnylam Pharmaceuticals

Overview

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, specializing in the discovery, development, and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. Founded in 2002, the company has established itself as a leader in RNAi technology, grounded in Nobel Prize-winning research in gene silencing and supported by a robust pipeline and five approved RNAi therapeutics.

The company develops medicines targeting rare and common conditions, with approved drugs for transthyretin amyloidosis, acute hepatic porphyria, primary hyperoxaluria, and hypercholesterolemia. Alnylam advances investigational candidates for conditions such as gout and Alzheimer’s, while collaborating with major pharmaceutical and biotech firms to further its mission of transforming RNAi science into effective medicines.

Basic Information

Industry research
Founded 2002
Revenue $3.7B
Headquarters 675 W Kendall St, Cambridge, Massachusetts 02142-1168, United States
Languages English

Contact Details

Key Focus Areas & Initiatives

  • Discovery and development of RNA interference (RNAi) therapeutics
  • Gene silencing research and technology
  • Drug development for rare and common genetic diseases
  • Commercialization of approved RNAi medicines
  • Therapeutic pipeline for cardiovascular, metabolic, and neurological diseases
  • Clinical trials and investigator-initiated studies
  • Patient advocacy and access philosophy
  • Collaboration with pharmaceutical and biotech partners
  • Diversity, equity, and inclusion initiatives
  • Corporate responsibility and sustainability efforts
  • Genetic testing and precision medicine innovation

Technologies Used

  • ABB Distributed Control Systems (DCS)
  • AI
  • AVImark Rapport
  • Amazon AWS
  • Amazon SES
  • Amazon Virtual Private Cloud (Amazon VPC)
  • Analyzer
  • Android
  • BASE
  • Batch
  • Bootstrap Framework
  • Cisco Prime Infrastructure
  • Drupal
  • Electron
  • Excel4Apps
  • Facebook Custom Audiences
  • Facebook Login (Connect)
  • Facebook Widget
  • Flow
  • Gem
  • Google Analytics
  • Google Font API
  • Google Maps
  • Google Maps (Non Paid Users)
  • Google Tag Manager
  • HPLC
  • Homestead
  • Hotjar
  • IQMS
  • Intel Nios
  • IoT
  • Ironclad
  • Jira
  • LabWare LIMS
  • Linkedin Marketing Solutions
  • Micro
  • Microsoft Excel
  • Microsoft PowerPoint
  • Microsoft Project
  • Microsoft Word
  • Mimecast
  • Mobile Friendly
  • New Relic
  • Nginx
  • Olo
  • OnCore CTMS
  • OneTrust
  • Outlook
  • Pantheon
  • PyTorch
  • Python
  • Rackspace MailGun
  • Rapid7 InsightVM
  • Remote
  • SAP Ariba Platform
  • SAP Predictive Analytics
  • SAS Enterprise Guide
  • SAS/Graph
  • SS&C
  • Salesforce
  • Salesforce CRM Analytics
  • Salesforce Live Agent
  • Siemens Syngo Imaging
  • Slack
  • Spiceworks IP Scanner
  • TIBCO Spotfire
  • Taleo
  • Varnish
  • Veeva Systems
  • Vimeo
  • Wagtail CMS
  • Wider Planet
  • WordPress.org
  • YouTube
  • Zoomdata
  • empow

Affiliated Organizations & Regional Branches

    Need more information?

    Find decision makers, more insights and contact information about this company on Bitscale

    Start For Free

    Schedule your demo now!

    See how BitScale can supercharge your outbound sales in a 30-minute demo

    Start for Free

    Resources

    Careers

    Pricing

    homeCommunity

    Security

    SayData

    Β© 2026 Bitscale. Featherflow Technology Pvt Ltd.

    LinkedInTwitterInstagramYouTube
    AICPAGDPR
    CCPAISO
    LinkedInTwitterInstagramYouTube